Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06893406 · ClinicalTrials.gov registry record · NA

Cervical Myelopathy in Hip Fracture Patients

A NA study of Hip Fractures and Cervical Myelopathy, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
3
Study locations

NCT06893406 is a NA study of Hip Fractures and Cervical Myelopathy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 75 participants, below the 616-participant average among 15 other Hip Fractures trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06893406, a NA study of Hip Fractures and Cervical Myelopathy, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
3
Study locations

Study Summary

Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.

Interventions

  • DIAGNOSTIC_TEST Cervical MRI
  • OTHER History & Physical Exam

Study Locations (3)

Indiana

  • Indiana University North Hospital - Fishers
  • Eskenazi Hospital - Indianapolis
  • Indiana University Health Methodist Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-05-01
Est. Completion 2026-03-20
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06893406

The ClinicalTrials.gov registry entry for NCT06893406 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 616-participant average among 15 other Hip Fractures trials with a reported enrollment target (88% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which Cervical MRI is the first listed.

NCT06893406 reports 3 study locations spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06893406 about?

NCT06893406 is a clinical study titled "Cervical Myelopathy in Hip Fracture Patients". Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground...

What is the current status of trial NCT06893406?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-05-01. Estimated completion is 2026-03-20.

What conditions does trial NCT06893406 study?

This clinical trial studies the following conditions: Hip Fractures, Cervical Myelopathy.

What interventions are being tested in trial NCT06893406?

The interventions under investigation include: Cervical MRI (DIAGNOSTIC_TEST), History & Physical Exam (OTHER).

Who is sponsoring clinical trial NCT06893406?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06893406 being conducted?

This trial has 3 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.